Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy
BioNTech SE
BioNTech SE
Sichuan Baili Pharmaceutical Co., Ltd.
Washington University School of Medicine
Boehringer Ingelheim
National Cancer Institute (NCI)
Norwegian University of Science and Technology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
National Cancer Institute (NCI)
Georgetown University
Wake Forest University Health Sciences
Boehringer Ingelheim
H. Lee Moffitt Cancer Center and Research Institute
Boehringer Ingelheim
Debiopharm International SA
Massachusetts General Hospital
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
PharmaMar
M.D. Anderson Cancer Center
University of Chicago
Monte Rosa Therapeutics, Inc
Amgen
Daiichi Sankyo
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
AstraZeneca
Hoffmann-La Roche
Jonsson Comprehensive Cancer Center
AstraZeneca
Boundless Bio, Inc.
ImmunityBio, Inc.
Shanghai Henlius Biotech
Hoffmann-La Roche
Amgen
Amgen
Ohio State University Comprehensive Cancer Center
Amgen
M.D. Anderson Cancer Center
AstraZeneca
Case Comprehensive Cancer Center
AstraZeneca
Amgen
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
Washington University School of Medicine
AstraZeneca
AbbVie